Abstract
BackgroundPrior research suggests that psychiatric disorders could be linked to increased mortality among patients with COVID-19. However, whether all or specific psychiatric disorders are intrinsic risk factors of death in COVID-19 or whether these associations reflect the greater prevalence of medical risk factors in people with psychiatric disorders has yet to be evaluated. MethodsWe performed an observational, multicenter, retrospective cohort study to examine the association between psychiatric disorders and mortality among patients hospitalized for laboratory-confirmed COVID-19 at 36 Greater Paris University hospitals. ResultsOf 15,168 adult patients, 857 (5.7%) had an ICD-10 diagnosis of psychiatric disorder. Over a mean follow-up period of 14.6 days (SD = 17.9), 326 of 857 (38.0%) patients with a diagnosis of psychiatric disorder died compared with 1276 of 14,311 (8.9%) patients without such a diagnosis (odds ratio 6.27, 95% CI 5.40–7.28, p < .01). When adjusting for age, sex, hospital, current smoking status, and medications according to compassionate use or as part of a clinical trial, this association remained significant (adjusted odds ratio 3.27, 95% CI 2.78–3.85, p < .01). However, additional adjustments for obesity and number of medical conditions resulted in a nonsignificant association (adjusted odds ratio 1.02, 95% CI 0.84–1.23, p = .86). Exploratory analyses after the same adjustments suggested that a diagnosis of mood disorders was significantly associated with reduced mortality, which might be explained by the use of antidepressants. ConclusionsThese findings suggest that the increased risk of COVID-19–related mortality in individuals with psychiatric disorders hospitalized for COVID-19 might be explained by the greater number of medical conditions and the higher prevalence of obesity in this population and not by the underlying psychiatric disease.
Highlights
In this multicenter retrospective observational study involving 15,168 patients hospitalized for laboratory-confirmed COVID-19, we found that individuals with a diagnosis of psychiatric disorder had a 6-fold increased risk of mortality than those without this diagnosis
All individual psychiatric diagnoses were significantly associated with increased mortality when adjusting for age, sex, hospital, current smoking status, and medications according to compassionate use or as part of a clinical trial
Our analyses suggest that increased mortality in patients diagnosed with a psychiatric disorder compared to those without this diagnosis was mainly explained by the higher rates of medical risk factors, including greater number of medical conditions and higher prevalence of obesity, in this population
Summary
Prior studies [1,2,3,4,5,6,7,8,9,10] suggest that psychiatric disorders, including schizophrenia spectrum disorders [1,2,3,4,7], mood disorders [1,2,3,8], anxiety disorders [1], intellectual and developmental disabilities [9], substance-induced psychiatric disorders [1,2], and dementia [5] are associated with higher COVID-19-related mortality. Because these comorbidities are associated with increased COVID-19-related mortality [13], it is important to determine whether psychiatric disorders are independent risk factors for death due to COVID-19, or whether this association is explained by the greater rates of medical risk factors for severe COVID-19 in this population This issue is key in the context of worldwide infectious disease crisis [14,15,16], where limited resources, including vaccine distribution, are allocated based on vulnerability to develop severe COVID-19. Conclusions: These findings suggest that the increased risk of COVID-19-related mortality in individuals with psychiatric disorders hospitalized for COVID-19 might be explained by the greater number of medical conditions and the higher prevalence of obesity in this population, but not by the underlying psychiatric disease
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.